Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1993 May;77(5):274–279. doi: 10.1136/bjo.77.5.274

Clinical features of HTLV-I associated uveitis.

K Nakao 1, N Ohba 1
PMCID: PMC504504  PMID: 8100446

Abstract

The prevalence of human T cell lymphoma virus type 1 (HTLV-I) was studied among patients with endogenous uveitis. Twelve (15.8%) of 76 uveitis patients with known aetiology or clinical entity were seropositive, the prevalence being comparable with that in the general population of the southwestern area of Japan where HTLV-I is highly endemic. In the comparison, 32 (41.0%) of 78 patients with aetiology or entity undefined uveitis were seropositive for HTLV-I, which indicated a significantly higher seroprevalence than controls matched for sex and age. The 32 cases of clinical entity undefined, HTLV-I positive uveitis were characterised by acute granulomatous or non-granulomatous uveal reactions which were accompanied by vitreous opacities and retinal vasculitis. The uveal inflammatory and retinal vascular changes responded well to topical and/or systemic corticosteroids and resolved in a few weeks in the majority of cases with favourable visual outcome. The disease affected one or both eyes, and eight cases (25%) showed recurrence within a year. The general condition of the patients remained well otherwise during a follow up study (mean follow up time 15.4 months), except for three cases with a possible association of hyperthyroidism. These findings provide additional information favouring an association between HTLV-I and isolated uveitis, a new disease entity which should be termed HTLV-I-associated uveitis.

Full text

PDF
274

Images in this article

276Image
on p.276
276Image
on p.276
276Image
on p.276
276Image
on p.276
277Image
on p.277
277Image
on p.277
277Image
on p.277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  2. Hayasaka S., Takatori Y., Noda S., Setogawa T., Hayashi H. Retinal vasculitis in a mother and her son with human T-lymphotropic virus type 1 associated myelopathy. Br J Ophthalmol. 1991 Sep;75(9):566–567. doi: 10.1136/bjo.75.9.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K. I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476–6480. doi: 10.1073/pnas.78.10.6476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lauer S. A., Fischer J., Jones J., Gartner S., Dutcher J., Hoxie J. A. Orbital T-cell lymphoma in human T-cell leukemia virus-I infection. Ophthalmology. 1988 Jan;95(1):110–115. doi: 10.1016/s0161-6420(88)33231-8. [DOI] [PubMed] [Google Scholar]
  5. Mochizuki M., Watanabe T., Yamaguchi K., Takatsuki K., Yoshimura K., Shirao M., Nakashima S., Mori S., Araki S., Miyata N. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992 Mar;83(3):236–239. doi: 10.1111/j.1349-7006.1992.tb00092.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Morgan O. S., Rodgers-Johnson P., Mora C., Char G. HTLV-1 and polymyositis in Jamaica. Lancet. 1989 Nov 18;2(8673):1184–1187. doi: 10.1016/s0140-6736(89)91793-5. [DOI] [PubMed] [Google Scholar]
  7. Nakao K., Matsumoto M., Ohba N. Seroprevalence of antibodies to HTLV-I in patients with ocular disorders. Br J Ophthalmol. 1991 Feb;75(2):76–78. doi: 10.1136/bjo.75.2.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Nakao K., Ohba N., Isashiki M., Isashiki Y., Unoki K., Osame M. Pigmentary retinal degeneration in patients with HTLV-I-associated myelopathy. Jpn J Ophthalmol. 1989;33(4):383–391. [PubMed] [Google Scholar]
  9. Nakao K., Ohba N., Matsumoto M. Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33(4):472–481. [PubMed] [Google Scholar]
  10. Ohba N., Matsumoto M., Sameshima M., Kabayama Y., Nakao K., Unoki K., Uehara F., Kawano K., Maruyama I., Osame M. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33(1):1–12. [PubMed] [Google Scholar]
  11. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol. 1987 Feb;21(2):117–122. doi: 10.1002/ana.410210203. [DOI] [PubMed] [Google Scholar]
  12. Sasaki K., Morooka I., Inomata H., Kashio N., Akamine T., Osame M. Retinal vasculitis in human T-lymphotropic virus type I associated myelopathy. Br J Ophthalmol. 1989 Oct;73(10):812–815. doi: 10.1136/bjo.73.10.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Spalton D. J., Nicholson F. HTLV-I infection in human disease. Br J Ophthalmol. 1991 Mar;75(3):174–175. doi: 10.1136/bjo.75.3.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Vernant J. C., Buisson G., Magdeleine J., De Thore J., Jouannelle A., Neisson-Vernant C., Monplaisir N. T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome. Lancet. 1988 Jan 23;1(8578):177–177. doi: 10.1016/s0140-6736(88)92744-4. [DOI] [PubMed] [Google Scholar]
  15. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031–2035. doi: 10.1073/pnas.79.6.2031. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES